Your Search Results

Coronary artery access and revascularisation after TAVI

21 Nov 2021 – From PCR London Valves 2021

Find out more about coronary access post-TAVI in this PCR London Valves 2021 session, witness a coronary intervention after self-expanding TAVI or SAVR in low-risk patients, and review two-year outcomes following TAVI or SAVR in patients stratified by need for revascularisation, among others!

Coronary artery access and revascularisation after TAVI

Emergent transcatheter therapy

21 Nov 2021 – From PCR London Valves 2021

This series of 3 videos presented during the PCR London Valves 2021 Congress allows you to appreciate an emergent mitral ViV implantation after a recent re-do bioprosthetic AVR, a cardiogenic shock after transfemoral mitral valve reconstruction, and MitraClip for torrential mitral regurgitation with Impella CP support.

Pacemaker implantation after TAVI

21 Nov 2021 – From PCR London Valves 2021

Through this series of videos from PCR London Valves 2021, learn about the early outcomes of using the novel frame alignment technique during TAVI to improve pacemaker rates, see how cusp overlap projection reduces the burden of permanent pacemaker implantation after TAVR, appreciate the clinical utility of...

Unusual situations in valvular interventions

21 Nov 2021 – From PCR London Valves 2021

Let's discover an electrosurgical removal of an entrapped central venous catheter, witness a coronary extra-adventitial hematoma complication of transcatheter tricuspid annuloplasty, and appreciate buddy balloon technique as bailout strategy during RVOT stent embolization, among others, in this special PCR London Valves 2021 session dedicated to unusual...

Unusual situations in valvular interventions

The PROTECTED TAVR study: Cerebral embolic protection during transcatheter aortic valve replacement

18 Sep 2022

Jonathan Curio provides his take on the PROTECTED TAVR study which was presented by Samir R. Kapadia at TCT 2022. The aim was to evaluate whether TAVR with cerebral embolic protection would reduce the rate of clinical stroke in transfemoral TAVR.

Author

Jonathan Curio

The PROTECTED TAVR study: Cerebral embolic protection during transcatheter aortic valve replacement

Outcomes in patients with atrial fibrillation randomized to receive LAA closure or oral anticoagulation: Primary results of the CHAMPION-AF clinical trial

28 Mar 2026

During the first Late-Breaking Trial session of the 2026 ACC Congress held in New Orleans, Saibal Kar, principal investigator of the CHAMPION-AF trial, presented the 3-year results of this groundbreaking study, which were simultaneously published in the NEJM (DOI: 10.1056/NEJMoa2517213).